News/Reports
I’m pleased to announce A. S. Freeman Advisors’ annual Global Trends in Medtech 2024 is available here for download and distribution. Key points in this year’s presentation include: The medtech industry will exceed $600 billion this year. The rise in elderly populations around the world will strain the financial resources of governments and insurance organizations Medical staffs will increasingly be driven to capacity as patient loads and dated workflow procedures strain care centers Medtech companies have discovered digitization as the most effective approach to improving physical and fiscal outcomes for all constituencies in healthcare Major OEMs are studying how to improve workflow in care settings and building that logic into devices Supply chains are shifting to better match OEMs preferred three tier structure, similar to the aerospace supply chain Opportunities still exist for smaller contract manufacturers to differentiate themselves from larger CMs who are starting to fill the prime contractor role on the most desirable programs As always, I am happy to present Global Trends to you or your firm. Please reach me at tfreeman@asfreeman.com with questions, comments, or requests. Best regards, Tony Freeman
DuPont de Nemours, Inc. (NYSE:DD) announced on June 25 that it will acquire Donatelle Plastics, a well-established medtech contract manufacturer based in New Brighton, MN. No terms were announced. The transaction is expected to close later this year. Though Dupont has long supplied branded materials such as Tyvek™ to the medtech industry, the purchase of Donatelle reinforces their expansion into medtech contract manufacturing. Last year DuPont acquired Spectrum Plastics Group, supplementing their contract manufacturing work with Liveo™ silicone products, originally a Dow Corning product line. DuPont’s strategy of building out contract manufacturing to complement its global position in specialty materials bears watching. For more information please visit: https://www.dupont.com/news/dupont-to-acquire-donatelle-plastics-incorporated.html Please contact tfreeman@asfreeman.com with questions and comments. A. S. Freeman Advisors was not involved in this transaction. We are reporting the deal as a point of interest to our clients and colleagues.
In my latest column for MPO, I discuss the risks new weight-loss drugs (GLP1s) may pose to OEMs and contract manufacturers. Heavy Harm or Slim Chance? The Impact of GLP1s on Medtech The highest existential risk is not to OEMs but to contract manufacturers specializing in the areas where GLP1s will delay surgeries. Read the column here.
A.S. Freeman will be in Anaheim, California for MD&M West 2024, which takes place from February 6-8, as well as for the annual mdmX Networking event Monday February 5. If you would like to meet up in Anaheim, please drop me a line, or give me a call at 917-868-0772.
The Annual mdmX Networking Event is slightly different this year – it will still be the Monday before MD&M West opens, but in a reception format. Please join us for an evening of conversation with other leaders in the medical device supply chain. Join the Conversation 2024 Annual mdmX Networking Reception Anaheim California Monday, February 5, 2024 5:30-8:30pm The Annual mdmX (Medical Device Manufacturers eXchange) Networking Reception returns Monday, February 5, 2024 in Anaheim, California. Join us for cocktails and hors d’oeuvres at McCormick & Schmick’s Grille (321 W Katella Ave., Anaheim, CA 92802) in a relaxed setting with other leaders in the medical device supply chain. As in past years, business owners and senior executives will compare notes, share insights, and talk about the future of the industry. There is no agenda and no pressure. Please come to be part of the conversation. Get your tickets at Eventbrite Click here to add this event to your calendar. What is mdmX? The Medical Device Manufacturers eXchange (mdmX) is an informal association of owners and senior executives of medical device supply chain manufacturers and service providers. We meet annually the evening before the MDM West Expo in Anaheim, California. There are no membership fees or obligations. The purpose of the evening is to create a once-a-year forum for supply chain business leaders to discuss, listen, learn, make new connections, and strengthen old friendships. It is a chance to discuss the bigger issues with those who share your experiences in leading companies in the supply chain.
I am honored to present The State of the Medtech Industry keynote address on October 18th at the MPO Summit in San Diego. I’ll cover the forces changing product lines and potentially introducing new competitors into the medtech supply chain.
I’m pleased to announce A. S. Freeman Advisors’ annual Global Trends in Medtech 2023 is available here for download and distribution. Key points in this year’s presentation include: Medtech market size and growth rate Demographic and economic trends reshaping OEM product lines for the next decades Redefinition of what constitutes a medical device The size and growth rate of the medical device supply chain Changing roles for the contract manufacturing incumbents? Strategies for participating in the digitization of devices and systems As always, I am happy to present Global Trends to you or your firm. Please reach me at tfreeman@asfreeman.com with questions, comments, or requests. Best regards, Tony Freeman